JP2023510212A5 - - Google Patents

Info

Publication number
JP2023510212A5
JP2023510212A5 JP2022540849A JP2022540849A JP2023510212A5 JP 2023510212 A5 JP2023510212 A5 JP 2023510212A5 JP 2022540849 A JP2022540849 A JP 2022540849A JP 2022540849 A JP2022540849 A JP 2022540849A JP 2023510212 A5 JP2023510212 A5 JP 2023510212A5
Authority
JP
Japan
Prior art keywords
imidazo
pyran
tetrahydro
phenoxyphenyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022540849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510212A (ja
JP7649311B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/140517 external-priority patent/WO2021136219A1/en
Publication of JP2023510212A publication Critical patent/JP2023510212A/ja
Publication of JP2023510212A5 publication Critical patent/JP2023510212A5/ja
Application granted granted Critical
Publication of JP7649311B2 publication Critical patent/JP7649311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022540849A 2020-01-02 2020-12-29 Btk阻害薬 Active JP7649311B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2020070034 2020-01-02
CNPCT/CN2020/070034 2020-01-02
CNPCT/CN2020/134601 2020-12-08
CN2020134601 2020-12-08
PCT/CN2020/140517 WO2021136219A1 (en) 2020-01-02 2020-12-29 Btk inhibitors

Publications (3)

Publication Number Publication Date
JP2023510212A JP2023510212A (ja) 2023-03-13
JP2023510212A5 true JP2023510212A5 (enExample) 2024-01-10
JP7649311B2 JP7649311B2 (ja) 2025-03-19

Family

ID=76685855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540849A Active JP7649311B2 (ja) 2020-01-02 2020-12-29 Btk阻害薬

Country Status (10)

Country Link
US (1) US12624039B2 (enExample)
EP (1) EP4087845A4 (enExample)
JP (1) JP7649311B2 (enExample)
CN (2) CN114945574B (enExample)
AU (1) AU2020419422B2 (enExample)
BR (1) BR112022013227A2 (enExample)
CA (1) CA3163365A1 (enExample)
MX (1) MX2022008148A (enExample)
TW (1) TWI875911B (enExample)
WO (1) WO2021136219A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020436612A1 (en) * 2020-03-16 2022-09-01 Flash Therapeutics, Llc Compounds for treating or inhibiting recurrence of acute myeloid leukemia
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
CN115851606A (zh) * 2022-12-19 2023-03-28 北京爱思益普生物科技股份有限公司 Btk突变细胞株及其构建方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054827A2 (en) 2006-11-03 2008-05-08 Pharmacyclics, Inc. Bruton's tyrosine kinase activity probe and method of using
ES2396613T3 (es) * 2008-05-19 2013-02-22 OSI Pharmaceuticals, LLC Imidazopirazinas e imidazotriazinas sustituidas
US8940725B2 (en) 2010-05-31 2015-01-27 Ono Pharmaceutical Co., Ltd. Purinone derivative
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
CA2833867A1 (en) 2013-11-21 2015-05-21 Pharmascience Inc. Protein kinase inhibitors
WO2016020901A1 (en) * 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
WO2016106652A1 (en) * 2014-12-31 2016-07-07 Merck Sharp & Dohme Corp. Biarylether imidazopyrazine btk inhibitors
US20180305350A1 (en) * 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN114605327B (zh) 2015-12-16 2025-03-11 洛克索肿瘤学股份有限公司 可用作激酶抑制剂的化合物
AU2015417922B2 (en) 2015-12-23 2018-12-20 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
US10640512B2 (en) * 2016-06-30 2020-05-05 Hangzhou Sanyintai Pharmaceutical Technology Co., Ltd. Imidazopyrazinamine phenyl derivative and use thereof
AU2017315343A1 (en) 2016-08-24 2019-02-28 Arqule, Inc. Amino-pyrrolopyrimidinone compounds and methods of use thereof
CN111454268B (zh) 2019-01-18 2023-09-08 明慧医药(上海)有限公司 作为布鲁顿酪氨酸激酶抑制剂的环状分子
CA3126940A1 (en) 2019-01-18 2020-07-23 Xibin Liao Bruton's tyrosine kinase inhibitors
CN113943294A (zh) 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途

Similar Documents

Publication Publication Date Title
JP7556010B2 (ja) PI3Kδ関連障害治療のためのピラゾロピリミジン誘導体の使用
JP6574039B2 (ja) Pi3k阻害剤としてのヘテロシクリルアミン
US11130767B2 (en) Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US9617258B2 (en) Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
JP7324836B2 (ja) Jak阻害剤としてのジメチルアミノアゼチジンアミド
SI3087075T1 (en) SYK INHIBITORS
JP2017052805A5 (enExample)
US20070254892A1 (en) Dihydropyrazolopyrimidinone derivatives
JP2022545364A5 (enExample)
EA040464B1 (ru) Амиды диметиламиноазетидина в качестве jak ингибиторов
EA045057B1 (ru) Лечение b-клеточных злокачественных новообразований с применением комбинации ингибиторов jak и pi3k